Inova Center of Outcomes Research, Fairfax, Virginia, USA; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Yale University School of Medicine, New Haven, Connecticut, USA.
JACC Cardiovasc Interv. 2024 Apr 22;17(8):961-978. doi: 10.1016/j.jcin.2024.01.284. Epub 2024 Apr 8.
Aging is the gradual decline in physical and physiological functioning leading to increased susceptibility to stressors and chronic illnesses, including cardiovascular disease. With an aging global population, in which 1 in 6 individuals will be older than 60 years by 2030, interventional cardiologists are increasingly involved in providing complex care for older individuals. Although procedural aspects remain their main clinical focus, interventionalists frequently encounter age-associated risks that influence eligibility for invasive care, decision making during the intervention, procedural adverse events, and long-term management decisions. The unprecedented growth in transcatheter interventions, especially for structural heart diseases at extremes of age, have pushed age-related risks and implications for cardiovascular care to the forefront. In this JACC state-of-the-art review, the authors provide a comprehensive overview of the aging process as it relates to cardiovascular interventions, with special emphasis on the difference between chronological and biological aging. The authors also address key considerations to improve health outcomes for older patients during and after their invasive cardiovascular care. The role of "gerotherapeutics" in interventional cardiology, technological innovation in measuring biological aging, and the integration of patient-centered outcomes in the older adult population are also discussed.
衰老是指身体和生理机能的逐渐下降,导致对压力和慢性疾病(包括心血管疾病)的易感性增加。随着全球人口老龄化,到 2030 年,每 6 个人中就有 1 个年龄在 60 岁以上,介入心脏病专家越来越多地参与为老年人提供复杂的护理。尽管程序方面仍然是他们的主要临床重点,但介入心脏病专家经常遇到与年龄相关的风险,这些风险会影响侵入性护理的资格、介入期间的决策、程序不良事件和长期管理决策。经导管介入治疗的空前增长,尤其是在年龄极端的结构性心脏病方面,将与心血管护理相关的与年龄相关的风险和影响推到了前沿。在这篇 JACC 最新综述中,作者全面概述了与心血管介入相关的衰老过程,特别强调了生理年龄和实际年龄之间的差异。作者还讨论了改善老年患者在侵入性心血管护理期间和之后的健康结果的关键注意事项。介入心脏病学中的“老年治疗学”、测量生理年龄的技术创新以及将以患者为中心的结果纳入老年人群体也是讨论的内容。